Tech and Biotech: Two Madison biotechs to advance with drug trials; a medical device company receives funds

Madison Vaccines, meanwhile, will have one of its prostate cancer vaccines involved in a clinical trial at UW-Madison as a result of a $1.5 million grant to Dr. Douglas McNeel, UW associate professor of medicine in hematology/oncology.